Anastasiou D: Difference between revisions
From Bioblast
(Created page with "{{Person |lastname=Anastasiou |firstname=Dimitrios |title= |[email protected] |address=Developmental Biology / Physiology and Metabolism / Stem Cell ...") |
No edit summary |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
|lastname=Anastasiou | |lastname=Anastasiou | ||
|firstname=Dimitrios | |firstname=Dimitrios | ||
| | |institution=Cancer Metabolism Laboratory | ||
The Francis Crick Institute | |||
|address= | |address=The Ridgeway | ||
|area code=NW7 1AA | |||
|city=London | |||
|country=United Kingdom | |||
The Ridgeway | |weblink=http://www.crick.ac.uk/dimitrios-anastasiou | ||
London | |||
}} | }} | ||
{{Labelingperson}} |
Latest revision as of 21:36, 18 March 2018
Name | Anastasiou Dimitrios, |
---|---|
Institution | Cancer Metabolism Laboratory
The Francis Crick Institute |
Address | The Ridgeway, NW7 1AA |
City | London |
State/Province | |
Country | United Kingdom |
Weblink | http://www.crick.ac.uk/dimitrios-anastasiou |
O2k-Network Lab | UK London Anastasiou D |
Labels:
Publications
Published | Reference | |
---|---|---|
Fets 2022 Commun Biol | 2022 | Fets L, Bevan N, Nunes PM, Campos S, Dos Santos MS, Sherriff E, MacRae JI, House D, Anastasiou D (2022) MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine. https://doi.org/10.1038/s42003-022-03805-y |
Fets 2018 Nat Chem Biol | 2018 | Fets L, Driscoll PC, Grimm F, Jain A, Nunes PM, Gounis M, Doglioni G, Papageorgiou G, Ragan TJ, Campos S, Silva Dos Santos M, MacRae JI, O'Reilly N, Wright AJ, Benes CH, Courtney KD, House D, Anastasiou D (2018) MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG. Nat Chem Biol 14:1032-42. |